Got a good line of products, but the share price seem to go down , could it be due to the weak us dollar.

this is just one of the drugs in AZN's pipeline
though it's not a stock i have followed, today's fall looks more like a buying opp than the time to jump ship

19/04/2018

Interesting

--=-=-=

AstraZeneca lung cancer drug Tagrisso gets FDA approval
StockMarketWire.com
AstraZeneca said Thursday the US Food and Drug Administration approved its lung cancer treatment Tagrisso for the first-line treatment of patients with metastatic non-small cell lung cancer.

The approval comes after the results of the phase III FLAURA trial, showed Tagrisso met the primary endpoint.

'Today's FDA approval of Tagrisso in the 1st-line setting is an exciting milestone for patients and our company. Tagrisso delivered unprecedented medianprogression-free survival data across all pre-specified patient subgroups, including patients with or without CNS metastases, and could prolong the lives of more patients without their tumours growing or spreading,' said Dave Fredrickson, Executive Vice President, Head of the Oncology Business Unit at AstraZeneca.

Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLC
BFN
Jefferies International today downgrades its investment rating on AstraZeneca PLC (LON:AZN) to hold (from buy) and cut its price target to 5975p (from 6200p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk

-=-=-=-=-=

And the price goes down.